Skip to ContentSkip to Navigation
Practical matters How to find us dr. F.A. Holtkamp


Cardiovascular outcome trials in patients with chronic kidney disease: Challenges associated with selection of patients and endpoints

Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome

Langetermijnstudies gewenst voor nieuwe cholesterolverlagers: PCSK9-remmers welkom voor hoogrisicopatiënt die niet uitkomt met statine

The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors

Safety information on QT-interval prolongation: Comparison of European Union and United States drug labeling

Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers

Pre-renal success Reply

Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function

Monitoring Kidney Function and Albuminuria in Patients With Diabetes

Read more